Prot. VX20-880-101: A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of VX-880 in Subjects Who Have Type 1 Diabetes Mellitus with Impaired Hypoglycemic Awareness and Severe Hypoglycemia

Project: Research project

Project Details

StatusActive
Effective start/end date12/14/21 → 12/14/24

Funding

  • Vertex Pharmaceuticals Incorporated (Prot. VX20-880-101)